Introduction The management and care of tuberculosis(TB) in organ transplantation recipients is challenging. Recipients are more likely to develop disseminated TB and experience more atypical clinical symptoms, more significant treatment-related toxicity, and more unfavorable outcomes than the general population.1 Contezolid (Youxitai ®) is an orally administered novel oxazolidinone antibiotic developed in China.2 It has been mainly used to treat complicated gram-positive bacteria infections.3–5 Several vitro studies also demonstrated bactericidal activity against Mycobacterium tuberculosis.6,7 Recent clinical case reports also indicate it is effective for active tuberculosis, with a lower
Hence then, the article about successful treatment of intractable tuberculous peritonitis in a woman idr was published today ( ) and is available oncanadian news today ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Successful Treatment of Intractable Tuberculous Peritonitis in a Woman | IDR )